MEDA | 7,982 Euro | -0,049 -0,61 % | |
| WKN: 935166 ISIN: SE0000221723 Ticker-Symbol: M5E | Frankfurt | 10.02.12 | 09:44 Uhr |
Branche PharmaAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 23.01. | Perrigo (PRGO) Files ANDA for Generic Astepro Nasal Spray; Meda Pharma Files Patent Suit | 2 | StreetInsider.com | |
| 23.01. | Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals | 60 | PR Newswire | |
| ALLEGAN, Mich., Jan. 23, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug... Mehr lesen zu: Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals | ||||
| 29.12. | MEDA Announces Legislation on Renewable Energy / Says Renew Missouri Petition Would Result in Excessive Rate Increases on Missourians | 54 | MarketWire | |
| JEFFERSON CITY, MO -- (Marketwire) -- 12/29/11 -- Today the Missouri Energy Development Association (MEDA) announced it will propose renewable energy legislation during the next session of the Missouri... Mehr lesen zu: MEDA Announces Legislation on Renewable Energy / Says Renew Missouri Petition Would Result in Excessive Rate Increases on Missourians | ||||
| 15.12. | Meda Announces PDUFA Timeline for Dymista | 54 | Business Wire | |
| Regulatory News:
FDA, the U.S. Food and Drug Administration, has informed Meda
(STO:MEDAA) that the PDUFA (Prescription Drug User Fee Act) date for
... Mehr lesen zu: Meda Announces PDUFA Timeline for Dymista | ||||
| 09.12. | MEDA: Collaboration with Omega Pharma for SB12 | 56 | Business Wire | |
| Regulatory News:
Meda (STO:MEDAA) has signed a 5-year collaboration agreement with Omega
Pharma for SB12 in France, Italy, Belgium and Greece. Omega Pharma... Mehr lesen zu: MEDA: Collaboration with Omega Pharma for SB12 | ||||
| 06.12. | MEDA: Astepro patent granted | 36 | Business Wire | |
| Regulatory News:
The United States Patent and Trademark Office (USPTO) today issued a
patent related to Astepro (azelastine) nasal spray. This patent will... Mehr lesen zu: MEDA: Astepro patent granted | ||||
| 30.11. | Moberg Derma AB: Moberg Derma and Meda Extend License Agreement | 30 | Business Wire | |
| Regulatory News:
Moberg Derma AB (publ.)(STO:MOB) and Meda have entered into an
additional license agreement for Nalox™ - Moberg Derma's patented
product... Mehr lesen zu: Moberg Derma AB: Moberg Derma and Meda Extend License Agreement | ||||
| 17.11. | Meda Acquires Treo | 35 | Business Wire | |
| Regulatory News:
Meda (STO:MEDAA) has agreed to acquire three well-established Nordic OTC
drugs from McNeil AB/Cilag GmbH International, members of the Johnson... Mehr lesen zu: Meda Acquires Treo | ||||
| 02.11. | Meda AB (publ) – Interim report, January-September 2011 | 49 | Business Wire | |
| Regulatory News:
Meda AB (STO:MEDAA):
· Group net sales reached SEK 9,400 million (8,561). At fixed currency
rates, sales increased 19%.
... Mehr lesen zu: Meda AB (publ) – Interim report, January-September 2011 | ||||
| 28.10. | MEDA: Dymista Filed in Europe | 39 | Business Wire | |
| Regulatory News:
The marketing authorization application for Dymista (a novel formulation
of azelastine hydrochloride and fluticasone propionate) has been... Mehr lesen zu: MEDA: Dymista Filed in Europe | ||||
| 21.10. | MEDA: Nomination Committee Appointed | 41 | Business Wire | |
| Regulatory News:
As per specifications set at Meda's 2011 annual general meeting, a
nomination committee has been appointed. It consists of:
... Mehr lesen zu: MEDA: Nomination Committee Appointed | ||||
| 19.09. | Moberg Derma AB: Moberg Derma and Meda Sign Agreement for Nalox in Europe | 72 | Business Wire | |
| Regulatory News:
Moberg Derma AB (STO:MOB)(OMX: MOB) and Meda AB have entered into a
license agreement covering rights for Nalox® - Moberg Derma's patented... Mehr lesen zu: Moberg Derma AB: Moberg Derma and Meda Sign Agreement for Nalox in Europe | ||||
| 19.09. | Meda Acquires Rights to Nalox in Europe | 51 | Business Wire | |
| Regulatory News:
Meda (STO:MEDAA) has acquired exclusive licensing rights to Nalox
(treatment of fungal nail infections/nail psoriasis) from Moberg Derma
... Mehr lesen zu: Meda Acquires Rights to Nalox in Europe | ||||
| Unternehmen / Aktien | Branche | Aktienkurs | Top-Nachrichten | |
|---|---|---|---|---|
| UNITED DRUG PLC | Gesundheitswesen | - | United Drug PLC: Holding in Company | |
| MEDIQ NV | Handel | -0,34 % | Mediq darf Assist kaufen | |
| K+S AG | Chemie | -2,21 % | Chart-Check K+S: Die Korrektur droht | |
| ESSILOR | Gesundheitswesen | +1,10 % | Essilor Signs Two New Partnership Agreements in China | |
| SANOFI SA | Pharma | -0,04 % | Ukraine to produce diphtheria vaccine using Sanofi Pasteur technology |
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
